Insider buying last 90 days
No open-market insider purchases were filed for CI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every CI insider filing, plotted on the chart in Gekko.Open CI in Gekko
Gekko Brief
AI summaryNov 4 closeCigna climbs 3% this week alongside gains for peer Elevance Health, as CVS Health tumbles 12% on plans to split its pharmacy, benefits, and insurance operations into two separate publicly traded companies by early 2028, despite CVS posting an earnings beat and raising guidance. Cigna itself heads into its own third-quarter 2026 earnings release, scheduled before the market open on 5 November, with analysts projecting a year-over-year decrease in earnings per share alongside revenue growth driven by pharmacy and premium gains, while questions persist about whether pharmacy growth can offset a profit decline at the Evernorth segment.
Cigna closes at $305.41, up 3.4%, sitting above both its 50-day average of $285.08 and 200-day average of $282.02, with the 50-day above the 200-day. The GekkoIndex reads 49.5, placing the stock in the Neutral zone, down 4.6 points over the past five sessions. Price stands 33.1% below Gekko Fair Value of $456.46.
Earnings arrive 5 November, before the open, zero days away and inside a typical 20-trading-day holding window; the prior release saw a 7.78 actual versus 7.58 estimate but produced a -5.9% reaction, with average absolute moves around results near 6.5%. Over the last 90 days, Congress recorded 2 buys and 0 sells. Seasonality from this point has averaged -2.1% over the next 20 trading days across 5 years, rising in 3 of them. Consensus among 12 firms shows 8 buy and 4 hold ratings, with a $342.29 target.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Cigna price vs fair value
Close $305.41200-day averageGekko Fair Value $456.46
Cigna quick facts
- Market cap
- $80.70B
- P/E ratio
- 12.2
- Forward P/E
- 8.9
- EPS, TTM
- $24.19
- Revenue, TTM
- $282.4B
- Profit margin
- 2.3%
- Dividend yield
- 2.06%
- Beta
- 0.25
- Volume
- 2.43M avg 1.50M
- 1-year return
- +18.1%
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±4.2%
- 50-day average
- $285.08
- 200-day average
- $282.02
- Next earnings
- Nov 5 before open
- Shares outstanding
- 264.2M
Cigna swing-trade checklist
Cigna scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $305.41 is above the 50-day ($285.08) and 200-day ($282.02) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
49.5, Neutral
Reading 49.5 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
33.1% below
Price is 33.1% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: Congress 2 buys / 0 sales.
See smart money - Earnings riskheadwind
Reports today
Reports on Nov 5, 2026, today — inside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
−2.1% on average
From this point in the calendar, the next 20 trading days averaged −2.1% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Cigna stock chart and price history
Cigna closed at $305.41 on Nov 4, 2026, +18.1% over the past year, inside a 52-week range of $255.53 to $316.27.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +11.3%
- 3 months
- +11.0%
- 6 months
- +8.3%
- 1 year
- +18.1%
The full CI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CI in Gekko
Follow Cigna through every session
Put CI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CI in GekkoFree for 7 days. No credit card required.
About Cigna
Cigna sells health insurance and related services to individuals, employers, unions, and government programs across the United States, with additional health coverage offered internationally to multinational employers and their mobile workforces. It is known for a broad mix of medical, pharmacy, dental, vision, and behavioral health products, along with Medicare plans for seniors and coverage sold both on and off public exchanges.
The business runs through two main arms. Evernorth handles pharmacy services, benefits administration, care management, and data-driven health solutions for health plans, employers, government bodies, and providers. Cigna Healthcare covers insurance products for insured and self-insured clients, seniors, and individual buyers, and also issues permanent life insurance policies that companies use to fund future employee benefit obligations. Products reach customers through brokers, consultants, direct sales to employers and unions, and both private and public insurance exchanges.
Cigna traces its founding to 1792 and is headquartered in Bloomfield, Connecticut. Its shares are listed on the NYSE under the ticker CI.
- Listed
- NYSE
- Sector
- Health services
- Industry
- Managed health care
- Website
- thecignagroup.com
Cigna GekkoIndex: the smart money zone
Cigna’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 49.5, in the Neutral zone, down 4.6 points over five sessions.
49.5Neutral
Down 4.6 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 41 | +2.5% | +6.4% | ||
| Accumulation | 232 | +0.9% | +1.8% | ||
| Neutral (current zone) | 394 | −0.6% | −1.9% | ||
| Distribution | 27 | −0.7% | +1.3% | ||
| Selling | 3 | Too few readings yet | |||
Average CI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the CI price, zone by zone.Track CI in Gekko
Is Cigna stock overvalued? Gekko Fair Value
Cigna trades 33.1% below Gekko Fair Value of $456.46, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Cigna shares are worth, recalculated every trading day.
$456.46
Gekko Fair Value, Nov 4, 2026
33.1% Undervalued
At the end of Aug 2026 the price was 14.0% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open CI in Gekko
Cigna insider and Congress trading
No open-market insider purchases were filed for Cigna, and members of Congress disclosed 2 purchases and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
2trades disclosed: 2 purchases and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 11 |
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 4 |
From congressional disclosures, which report amounts as ranges.
Buybacks
Cigna has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $280.0M
- As a share of market cap
- 0.35%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
3of the funds Gekko tracks hold CI.
1added0opened2trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Cigna earnings: next date and track record
Cigna reports on Nov 5, 2026, before the open (today), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected before the open, today
- EPS estimate
- $7.52
- Revenue estimate
- $72.64B
7 of 8reports beat the EPS estimate
±6.5%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Cigna Group reported Q2 2026 total revenues of $71.7 billion and adjusted EPS of $7.78, exceeding expectations for both Evernorth and Cigna Healthcare segments. Evernorth revenues grew 6% year-over-year, while Specialty and Care Services delivered 22% pretax adjusted earnings growth driven by Accredo and specialty pharmacy services. Faster-than-expected biosimilar and specialty generic adoption contributed to affordability improvements. After-tax special item charges totaled $153 million or $0.58 per share.
- Guidance
- Management reiterated full year 2026 financial outlook, incorporating anticipated share repurchases and dividends. Leadership expressed confidence in sustained momentum across Evernorth and Cigna Healthcare, citing strong execution and strategic positioning in specialty pharmacy and AI-driven care innovation.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $7.78 est $7.58 | $71.67B est $70.14B | −5.9% |
| Apr 30, 2026 | $7.79 est $7.61 | $68.49B est $66.29B | −3.2% |
| Feb 5, 2026 | $8.08 est $7.88 | $72.47B est $70.31B | +7.5% |
| Oct 30, 2025 | $7.83 est $7.64 | $69.75B est $67.58B | −18.3% |
| Jul 31, 2025 | $7.20 est $7.16 | $67.23B est $62.91B | −12.0% |
| May 2, 2025 | $6.74 est $6.35 | $65.50B est $60.20B | −0.6% |
| Jan 30, 2025 | $6.64 est $7.82 | $65.72B est $63.44B | −3.0% |
| Oct 31, 2024 | $7.51 est $7.25 | $62.77B est $59.47B | +1.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Cigna stock forecast and analyst price targets
Analysts’ average 12-month price target for Cigna is $342.29, +12.1% from the last close, from 12 firms rating the stock in the last 90 days.
$342.29consensus 12-month target, +12.1% from the last close
Now $305.41Avg $342.29
Low $290High $387
Each firm’s latest rating in the last 90 days: 12 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 23 | Piper Sandler | $370 | +21.1% |
| Oct 5 | Bernstein | $387 | +26.7% |
| Oct 2 | Piper Sandler | $370 | +21.1% |
| Oct 2 | Truist Financial | $350 | +14.6% |
| Oct 1 | Barclays | $310 | +1.5% |
−1.9%average 20-day move after past Neutral readings
−2.1%average move over the next 20 trading days in the last 5 years
±2.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Cigna seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Cigna averaged −2.1% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.4% | 3 of 5 |
| Next 10 trading days | −0.2% | 3 of 5 |
| Next 15 trading days | −0.4% | 2 of 5 |
| Next 20 trading days | −2.1% | 3 of 5 |
| Next 30 trading days | −2.3% | 3 of 5 |
For scale, CI’s typical 20-trading-day move in either direction is about 4.2%.
Cigna market cap and key statistics
Cigna’s market cap is $80.70B, with a P/E ratio of 12.2 and revenue of $282.4B over the last twelve months.
Valuation
- Market cap
- $80.70B
- P/E ratio
- 12.2
- Forward P/E
- 8.9
- EPS, TTM
- $24.19
- Gekko Fair Value
- $456.46
Trading
- Volume
- 2.43M
- Avg volume, 20 days
- 1.50M
- 52-week high
- $316.27
- 52-week low
- $255.53
- Shares outstanding
- 264.2M
Financials
- Revenue, TTM
- $282.4B
- Profit margin
- 2.3%
- Return on equity
- 16.8%
- Quarterly earnings growth, YoY
- +10.2%
Risk and income
- Beta
- 0.25
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±4.2%
- Dividend yield
- 2.06%
Cigna stock news this week
Coverage of Cigna this week reads neutral: 7 positive, 10 neutral and 1 negative headlines.
- Cigna Stock Has Gained Since Investor Day. Earnings Are Next.Barrons, Nov 4
- CVS Tumbles 12% on Plan to Split Into Two Companies Despite Earnings Beat; Elevance Health Rises 4%, Cigna Climbs 3%24/7 Wall St., Nov 4
- The Cigna Group stock heads into November 5 earnings releasead-hoc-news.de, Nov 4
- How to Earn $500 A Month From Cigna Stock Ahead Of Q3 EarningsBenzinga, Nov 4
- 61,368 Shares of Cigna Group $CI Bought by Associated Banc CorpDefense World, Nov 4
- Cigna Group $CI Stock Holdings Trimmed by ARGA Investment Management LPDefense World, Nov 4
Cigna peers
Cigna’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| UNHUnitedHealth | Neutral | 9.7% above |
| ELVElevance Health | Neutral | 31.6% below |
| HUMHumana | Neutral | 22.1% below |
| CNCCentene | Neutral | 13.6% below |
| MOHMolina Healthcare | Neutral | 34.2% below |
| OSCROscar Health | Neutral | 4.8% above |
A peer links to its own page where one exists.
Cigna stock FAQ
What is Cigna’s market cap?
Cigna’s market cap is $80.70B at the Nov 4, 2026 close of $305.41, with 264.2M shares outstanding. The shares trade on a P/E ratio of 12.2.
What is the Cigna stock forecast?
The consensus analyst 12-month price target for Cigna is $342.29, +12.1% from the last close. Of the 12 firms that rated the stock in the last 90 days, 8 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Cigna stock overvalued or undervalued?
On Gekko’s estimate Cigna is undervalued: the Nov 4, 2026 close of $305.41 is 33.1% below Gekko Fair Value of $456.46. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Cigna report earnings next?
Cigna is expected to report on Nov 5, 2026, before the market opens (today). Analysts expect earnings of $7.52 per share on revenue of $72.64B. Cigna beat the earnings estimate in 7 of its last 8 reports, moving 6.5% on average across the report.
What is Cigna’s 52-week high and low?
Cigna’s 52-week high is $316.27 and its 52-week low is $255.53; it closed at $305.41 on Nov 4, 2026, +18.1% over the past year. Over the last five years the shares peaked at $370.83 on Sep 16, 2024.
Is Cigna stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (trend, fair value and smart money), 2 as mixed (gekkoindex and seasonality) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Cigna the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.